Average Co-Inventor Count = 9.53
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Compugen Ltd. Corporation (31 from 60 patents)
31 patents:
1. 10098934 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
2. 9617336 - C10RF32 antibodies, and uses thereof for treatment of cancer
3. 9555087 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
4. 9428586 - Heparanase splice variant
5. 9428574 - Polypeptides and uses thereof for treatment of autoimmune disorders and infection
6. 9375466 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
7. 9255132 - Angiopoietin derived peptides
8. 9107862 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
9. 8987191 - Bioactive peptides and methods of using same
10. 8828940 - Method of treating an ischemia-reperfusion injury-related disorder by administering GPCR ligands
11. 8575107 - Clusterin derived peptide
12. 8529943 - Angiopoietin derived peptides
13. 8492329 - Bioactive peptides and methods of using same
14. 8415455 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
15. 8349801 - Peptide ligands for G-protein coupled receptors